Expression of Survlvin and p53 in human biiiary tract carcinoma cell line regulated by nanochemotherapy drug
- VernacularTitle:纳米化疗药物对胆管癌细胞中Survivin和p53表达的调节
- Author:
Ying SU
;
Xin WANG
;
Tao TANG
;
Bo CHEN
;
Jianwei ZHENG
;
Hong LI
;
Shengquan ZOU
- Publication Type:Journal Article
- Keywords:
Nanotechnology;
Genes,p53;
Survivin;
Chemotherapeutics
- From:
Chinese Journal of Postgraduates of Medicine
2008;31(14):12-15
- CountryChina
- Language:Chinese
-
Abstract:
Objective To determine the effect of nanochemotherapy drug on Survivin and p53 ex-pressed by human biliary traet carcinoma cell line QBC939.Methods Culturing the human biliary tract carcinoma cell line QBC939 in vitro and it was divided into five groups including saline,nanochemotherapy drug,nanopartiele withoul nanochemotherapy drug,5-FU and gemcitabine.Using the methods of MTT and flow cytometry to observe the growth of QBC939 which was dealt with different drugs.In addition,RT-PCR and Western blot were used to delect the expression of mRNA and protein by Survivin or p53.Results The expression of mRNA and protein by Survivin decreased in the following set:saline,nanoparlicle withoul nanochemotherapy drug,5-FU,gemcitabine and nanochemotherapy drug,respeclively.However,the ex-pression of mRNA and protein by p53 were in reverse order.The inhibiting action to QBC939 was obvious in nanochenmtherapy drng and the apoplotic rate was higher than others except for gemcitabine(P＜0.05). Conclusion Nanochemotherapy drug has significant effect on treatment cholangiocarcinoma in vilro,which may attribute to the down regulation of Survivin and up regulation of p53.
